Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

Gastroenterology
R N DuBoisA J Entingh

Abstract

Multiple studies show that continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) lowers the risk of colon cancer in humans and carcinogen-treated rodents. One target for NSAIDs is cyclooxygenase (COX), and two isoforms of this enzyme have been identified: COX-1 and COX-2. The present study was undertaken to determine if there is differential expression of COX in colonic tumors in azoxymethane-treated rats. COX-1 and COX-2 messenger RNA levels were determined by Northern blot analysis of total RNA isolated from colonic tumors and normal adjacent mucosa. COX-2 protein levels were determined by Western blotting analysis. Quantitation of relative band densities was performed using standard densitometry scanning techniques. There was a marked increase in COX-2 RNA levels in six of six colonic tumors compared with paired normal mucosa. In contrast, there was equivalent intensity of the COX-1 RNA transcript between the normal mucosa and tumor in all of the specimens examined. Western blotting analysis showed an increase in the level of the COX-2 protein in four of five of the colonic tumor samples. COX-2 but not COX-1 gene expression is markedly elevated in most colonic tumors examined in azoxymethane-treated rodents. COX-2 ...Continue Reading

Citations

Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M TsujiiR N DuBois
Jan 22, 1998·The American Journal of Physiology·B A Jones, G J Gores
Jan 12, 2000·Oncogene·C S WilliamsR N DuBois
Dec 22, 1999·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·T KoshibaM Imamura
Feb 11, 2000·Annals of the New York Academy of Sciences·C WilliamsR N DuBois
May 12, 2000·Alimentary Pharmacology & Therapeutics·R N Dubois
May 9, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·D VogiagisP E O'Brien
Feb 27, 2001·Journal of Surgical Oncology·K UefujiH Mochizuki
Apr 17, 2001·International Journal of Cancer. Journal International Du Cancer·H K RoyA Ratashak
May 19, 2001·Journal of Gastroenterology and Hepatology·A E SiricaZ Zhang
Oct 3, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J A Oviedo, M M Wolfe
May 7, 2002·Nature Reviews. Cancer·Patrick W MantyhSteve P Hunt
Jun 8, 2004·Endocrine Reviews·S K DeyHaibin Wang
Feb 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Naoko NihoKeiji Wakabayashi
Jul 5, 2005·Expert Opinion on Investigational Drugs·C S WilliamsR N DuBois
Oct 13, 2006·Current Opinion in Gastroenterology·R N Dubois
Mar 21, 2007·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Masahiko Tsujii
Jul 1, 2002·Environmental Health and Preventive Medicine·Bandaru S Reddy
Oct 13, 2011·Molecular and Cellular Biochemistry·Manpreet Kaur SainiSankar Nath Sanyal
Apr 14, 2012·Drug Metabolism Reviews·Jose J G MarinOscar Briz
Feb 25, 1998·Japanese Journal of Cancer Research : Gann·S NakatsugiK Wakabayashi
Mar 26, 2002·Journal of Toxicology and Environmental Health. Part a·I-Ching Ho, Te-Chang Lee
Dec 14, 2002·The Journal of Biological Chemistry·Wangsheng YuAlan P Fields
Oct 29, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·C W HouchenS M Cohn
Mar 26, 2003·The American Journal of Gastroenterology·Thomas J McGarrityMary K Howett
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Nikolaos G NikitakisJohn J Sauk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.